{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:05:36Z","timestamp":1789538736946,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04784-4","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:46:06Z","timestamp":1789537566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth differentiation factor-15 and body roundness index in relation to cardiometabolic risk in young adults with obesity"],"prefix":"10.1007","volume":"91","author":[{"given":"Omar Jasim","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassanain K.","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"4784_CR1","doi-asserted-by":"publisher","unstructured":"T. Eroglu, F. Capone, G.G. Schiattarella, The evolving landscape of cardiometabolic diseases. EBioMedicine. 109 (2024). https:\/\/doi.org\/10.1016\/j.ebiom.2024.105447","DOI":"10.1016\/j.ebiom.2024.105447"},{"issue":"12","key":"4784_CR2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/circresaha.123.322000","volume":"132","author":"UA Tahir","year":"2023","unstructured":"U.A. Tahir, R.E. Gerszten, Molecular biomarkers for cardiometabolic disease: risk assessment in young individuals. Circ. Res. 132(12), 1663\u20131673 (2023). https:\/\/doi.org\/10.1161\/circresaha.123.322000","journal-title":"Circ. Res."},{"issue":"5","key":"4784_CR3","doi-asserted-by":"publisher","first-page":"e0154288","DOI":"10.1371\/journal.pone.0154288","volume":"11","author":"MJ Pletcher","year":"2016","unstructured":"M.J. Pletcher, E. Vittinghoff, A. Thanataveerat, K. Bibbins-Domingo, A.E. Moran, Young adult exposure to cardiovascular risk factors and risk of events later in life: the Framingham Offspring Study. PLoS One. 11(5), e0154288 (2016). https:\/\/doi.org\/10.1371\/journal.pone.0154288","journal-title":"PLoS One"},{"key":"4784_CR4","doi-asserted-by":"publisher","first-page":"116116","DOI":"10.1016\/j.bcp.2024.116116","volume":"222","author":"M-J Lee","year":"2024","unstructured":"M.-J. Lee, J. Kim, The pathophysiology of visceral adipose tissues in cardiometabolic diseases. Biochem. Pharmacol. 222, 116116 (2024). https:\/\/doi.org\/10.1016\/j.bcp.2024.116116","journal-title":"Biochem. Pharmacol."},{"key":"4784_CR5","doi-asserted-by":"publisher","first-page":"1187735","DOI":"10.3389\/fcvm.2023.1187735","volume":"10","author":"A Cesaro","year":"2023","unstructured":"A. Cesaro et al., Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options. Front. Cardiovasc. Med. 10, 1187735 (2023). https:\/\/doi.org\/10.3389\/fcvm.2023.1187735","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"4784_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/ijerph21060757","volume":"21","author":"Y Wu","year":"2024","unstructured":"Y. Wu, D. Li, S.H. Vermund, Advantages and limitations of the body mass index (BMI) to assess adult obesity. Int. J. Environ. Res. Public. Health. 21(6), 757 (2024). https:\/\/doi.org\/10.3390\/ijerph21060757","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"23","key":"4784_CR7","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.3390\/diagnostics15233025","volume":"15","author":"M-D Tanasescu","year":"2025","unstructured":"M.-D. Tanasescu et al., Beyond BMI: rethinking obesity metrics and cardiovascular risk in the era of precision medicine. Diagnostics (Basel). 15(23), 3025 (2025). https:\/\/doi.org\/10.3390\/diagnostics15233025","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"4784_CR8","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/oby.20408","volume":"21","author":"DM Thomas","year":"2013","unstructured":"D.M. Thomas et al., Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obes. (Silver Spring). 21(11), 2264\u20132271 (2013). https:\/\/doi.org\/10.1002\/oby.20408","journal-title":"Obes. (Silver Spring)"},{"key":"4784_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.104285","author":"J Liu","year":"2025","unstructured":"J. Liu, Q. Shen, X. Wang, Novel body roundness index related to cardiovascular disease, diabetes and mortality: a systematic review and combined analysis. Nutr. Metab. Cardiovasc. Dis. (2025). https:\/\/doi.org\/10.1016\/j.numecd.2025.104285","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"4784_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12872-021-01905-x","volume":"21","author":"J Xu","year":"2021","unstructured":"J. Xu et al., Body roundness index is a superior indicator to associate with the cardiometabolic risk: evidence from a cross-sectional study with 17,000 Eastern-China adults. BMC Cardiovasc. Disord. 21(1), 97 (2021). https:\/\/doi.org\/10.1186\/s12872-021-01905-x","journal-title":"BMC Cardiovasc. Disord"},{"issue":"7","key":"4784_CR11","doi-asserted-by":"publisher","first-page":"e13023","DOI":"10.1111\/obr.13023","volume":"21","author":"S Rico-Mart\u00edn","year":"2020","unstructured":"S. Rico-Mart\u00edn, J.F. Calder\u00f3n-Garc\u00eda, P. S\u00e1nchez-Rey, C. Franco-Antonio, M. Mart\u00ednez Alvarez, J.F. S\u00e1nchez Mu\u00f1oz-Torrero, Effectiveness of body roundness index in predicting metabolic syndrome: a systematic review and meta-analysis. Obes. Rev. 21(7), e13023 (2020). https:\/\/doi.org\/10.1111\/obr.13023","journal-title":"Obes. Rev."},{"issue":"2","key":"4784_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/met.2023.0175","volume":"22","author":"N Murai","year":"2024","unstructured":"N. Murai et al., Body roundness index is better correlated with insulin sensitivity than body shape index in young and middle-aged Japanese persons. Metab. Syndr. Relat. Disord. 22(2), 151\u2013159 (2024). https:\/\/doi.org\/10.1089\/met.2023.0175","journal-title":"Metab. Syndr. Relat. Disord"},{"issue":"11","key":"4784_CR13","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1007\/s00125-025-06450-2","volume":"68","author":"SK Boddu","year":"2025","unstructured":"S.K. Boddu, C. Giannini, M.L. Marcovecchio, Metabolic disorders in young people around the world. Diabetologia. 68(11), 2374\u20132385 (2025). https:\/\/doi.org\/10.1007\/s00125-025-06450-2","journal-title":"Diabetologia"},{"issue":"3","key":"4784_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.31083\/j.rcm2403081","volume":"24","author":"A Schwarz","year":"2023","unstructured":"A. Schwarz, R. Kinscherf, G.A. Bonaterra, Role of the stress- and inflammation-induced cytokine GDF-15 in cardiovascular diseases: from basic research to clinical relevance. Rev. Cardiovasc. Med. 24(3), 81 (2023). https:\/\/doi.org\/10.31083\/j.rcm2403081","journal-title":"Rev. Cardiovasc. Med."},{"key":"4784_CR15","doi-asserted-by":"publisher","first-page":"0832","DOI":"10.34133\/research.0832","volume":"8","author":"T Tian","year":"2025","unstructured":"T. Tian, M. Liu, P.J. Little, H. Strijdom, J. Weng, S. Xu, Emerging roles of GDF15 in metabolic and cardiovascular diseases. Res. (Wash D C). 8, 0832 (2025). https:\/\/doi.org\/10.34133\/research.0832","journal-title":"Res. (Wash D C)"},{"issue":"1","key":"4784_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/medicina62010132","volume":"62","author":"R-E Alexa","year":"2026","unstructured":"R.-E. Alexa et al., Growth differentiation factor 15 as a link between obesity, subclinical atherosclerosis, and heart failure: a systematic review. Med. (Kaunas). 62(1), 132 (2026). https:\/\/doi.org\/10.3390\/medicina62010132","journal-title":"Med. (Kaunas)"},{"key":"4784_CR17","doi-asserted-by":"publisher","first-page":"116809","DOI":"10.1016\/j.biopha.2024.116809","volume":"176","author":"J Li","year":"2024","unstructured":"J. Li, X. Hu, Z. Xie, J. Li, C. Huang, Y. Huang, Overview of growth differentiation factor 15 (GDF15) in metabolic diseases. Biomed. Pharmacother. 176, 116809 (2024). https:\/\/doi.org\/10.1016\/j.biopha.2024.116809","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"4784_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.7570\/jomes22010","volume":"32","author":"D Roy","year":"2023","unstructured":"D. Roy et al., Analyzing the association of visceral adipose tissue growth differentiation factor-15 and microRNA in type 2 diabetes mellitus. J. Obes. Metab. Syndr. 32(1), 64 (2023). https:\/\/doi.org\/10.7570\/jomes22010","journal-title":"J. Obes. Metab. Syndr."},{"issue":"4","key":"4784_CR19","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.3390\/ijms25042338","volume":"25","author":"T Vilari\u00f1o-Garc\u00eda","year":"2024","unstructured":"T. Vilari\u00f1o-Garc\u00eda et al., Role of leptin in obesity, cardiovascular disease, and type 2 diabetes. Int. J. Mol. Sci. 25(4), 2338 (2024). https:\/\/doi.org\/10.3390\/ijms25042338","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"4784_CR20","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/eurheartj\/ehaf937","volume":"47","author":"B Kurt","year":"2026","unstructured":"B. Kurt et al., C-reactive protein and cardiovascular risk in the general population. Eur. Heart J. 47(15), 1799\u20131810 (2026). https:\/\/doi.org\/10.1093\/eurheartj\/ehaf937","journal-title":"Eur. Heart J."},{"issue":"2","key":"4784_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/biomedicines12020363","volume":"12","author":"JC Lizarzaburu-Robles","year":"2024","unstructured":"J.C. Lizarzaburu-Robles, W.H. Herman, A. Garro-Mendiola, A. Gald\u00f3n Sanz-Pastor, O. Lorenzo, Prediabetes and cardiometabolic risk: the need for improved diagnostic strategies and treatment to prevent diabetes and cardiovascular disease. Biomedicines. 12(2), 363 (2024). https:\/\/doi.org\/10.3390\/biomedicines12020363","journal-title":"Biomedicines"},{"key":"4784_CR22","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.obpill.2024.100108","volume":"10","author":"HE Bays","year":"2024","unstructured":"H.E. Bays et al., Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. Obes. Pillars. 10, 100108 (2024). https:\/\/doi.org\/10.1016\/j.obpill.2024.100108","journal-title":"Obes. Pillars"},{"key":"4784_CR23","unstructured":"World Health Organization: Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. World Health Organization, Geneva, (2000)"},{"issue":"16","key":"4784_CR24","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"K.G. Alberti et al., Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640\u20131645 (2009). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644","journal-title":"Circulation"},{"issue":"Suppl 1","key":"4784_CR25","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee, 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care. 47(Suppl 1), S20\u2013S42 (2024). https:\/\/doi.org\/10.2337\/dc24-S002","journal-title":"Diabetes Care"},{"issue":"15","key":"4784_CR26","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","volume":"168","author":"RP Wildman","year":"2008","unstructured":"R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, M.R. Sowers, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999\u20132004). Arch. Intern. Med. 168(15), 1617\u20131624 (2008). https:\/\/doi.org\/10.1001\/archinte.168.15.1617","journal-title":"Arch. Intern. Med."},{"key":"4784_CR27","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1186\/s12889-024-18577-9","volume":"24","author":"Z Sedaghat","year":"2024","unstructured":"Z. Sedaghat, S. Khodakarim, S. Sabour, M. Valizadeh, M. Barzin, S.A. Nejadghaderi, F. Azizi, The effect of obesity phenotype changes on cardiovascular outcomes in adults older than 40 years in the prospective cohort of the Tehran Lipid and Glucose Study (TLGS): joint model of longitudinal and time-to-event data. BMC Public. Health. 24, 1090 (2024). https:\/\/doi.org\/10.1186\/s12889-024-18577-9","journal-title":"BMC Public. Health"},{"issue":"5","key":"4784_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","volume":"111","author":"TG Pickering","year":"2005","unstructured":"T.G. Pickering et al., Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 111(5), 697\u2013716 (2005). https:\/\/doi.org\/10.1161\/01.CIR.0000154900.76284.F6","journal-title":"Circulation"},{"issue":"6","key":"4784_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499\u2013502 (1972). https:\/\/doi.org\/10.1093\/clinchem\/18.6.499","journal-title":"Clin. Chem."},{"key":"4784_CR30","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2147\/DMSO.S302033","volume":"14","author":"L Cai","year":"2021","unstructured":"L. Cai, C. Li, Y. Wang, Y. Mo, J. Yin, X. Ma, Increased serum GDF15 related to improvement in metabolism by lifestyle intervention among young overweight and obese adults. Diabetes Metab. Syndr. Obes. 14, 1195\u20131202 (2021). https:\/\/doi.org\/10.2147\/DMSO.S302033","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"4784_CR31","doi-asserted-by":"publisher","first-page":"490842","DOI":"10.1155\/2015\/490842","volume":"2015","author":"R Adela","year":"2015","unstructured":"R. Adela, S.K. Banerjee, GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J. Diabetes Res. 2015, 490842 (2015). https:\/\/doi.org\/10.1155\/2015\/490842","journal-title":"J. Diabetes Res."},{"key":"4784_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fcvm.2020.00103","volume":"7","author":"S Sarkar","year":"2020","unstructured":"S. Sarkar et al., Serum GDF15, a promising biomarker in obese patients undergoing heart surgery. Front. Cardiovasc. Med. 7, 103 (2020). https:\/\/doi.org\/10.3389\/fcvm.2020.00103","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"4784_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11357-021-00370-w","volume":"44","author":"A Carballo-Casla","year":"2022","unstructured":"A. Carballo-Casla et al., Metabolic syndrome and growth differentiation factor 15 in older adults. Geroscience. 44(2), 867\u2013880 (2022). https:\/\/doi.org\/10.1007\/s11357-021-00370-w","journal-title":"Geroscience"},{"key":"4784_CR34","doi-asserted-by":"publisher","first-page":"101569","DOI":"10.1016\/j.arr.2022.101569","volume":"75","author":"M Conte","year":"2022","unstructured":"M. Conte, C. Giuliani, A. Chiariello, V. Iannuzzi, C. Franceschi, S. Salvioli, GDF15, an emerging key player in human aging. Ageing Res. Rev. 75, 101569 (2022). https:\/\/doi.org\/10.1016\/j.arr.2022.101569","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"4784_CR35","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.jpha.2023.12.003","volume":"14","author":"Y Han","year":"2024","unstructured":"Y. Han et al., New advances of adiponectin in regulating obesity and related metabolic syndromes. J. Pharm. Anal. 14(5), 100913 (2024). https:\/\/doi.org\/10.1016\/j.jpha.2023.12.003","journal-title":"J. Pharm. Anal."},{"issue":"6","key":"4784_CR36","doi-asserted-by":"publisher","first-page":"e0198889","DOI":"10.1371\/journal.pone.0198889","volume":"13","author":"J Reneau","year":"2018","unstructured":"J Reneau et al., Effect of adiposity on tissue-specific adiponectin secretion. PLoS One. 13(6), e0198889 (2018). https:\/\/doi.org\/10.1371\/journal.pone.0198889.","journal-title":"PLoS One"},{"issue":"2","key":"4784_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2337\/dc06-1362","volume":"30","author":"M Bl\u00fcher","year":"2007","unstructured":"M. Bl\u00fcher et al., Total and high-molecular-weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care. 30(2), 280\u2013285 (2007). https:\/\/doi.org\/10.2337\/dc06-1362","journal-title":"Diabetes Care"},{"issue":"4","key":"4784_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41580-023-00680-1","volume":"25","author":"CE Hagberg","year":"2024","unstructured":"C.E. Hagberg, K.L. Spalding, White adipocyte dysfunction and obesity-associated pathologies in humans. Nat. Rev. Mol. Cell. Biol. 25(4), 270\u2013289 (2024). https:\/\/doi.org\/10.1038\/s41580-023-00680-1","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"6","key":"4784_CR39","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00125-016-3933-4","volume":"59","author":"V Pellegrinelli","year":"2016","unstructured":"V. Pellegrinelli, S. Carobbio, A. Vidal-Puig, Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues. Diabetologia. 59(6), 1075\u20131088 (2016). https:\/\/doi.org\/10.1007\/s00125-016-3933-4","journal-title":"Diabetologia"},{"issue":"2","key":"4784_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3904\/kjim.2024.221","volume":"40","author":"M-J Kim","year":"2025","unstructured":"M.-J. Kim et al., Persistent influence of past obesity on current adiponectin levels and mortality in patients with type 2 diabetes. Korean J. Intern. Med. 40(2), 299 (2025). https:\/\/doi.org\/10.3904\/kjim.2024.221","journal-title":"Korean J. Intern. Med."},{"issue":"22","key":"4784_CR41","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/CIR.0000000000001185","volume":"148","author":"M Mietus-Snyder","year":"2023","unstructured":"M. Mietus-Snyder et al., Next generation, modifiable cardiometabolic biomarkers: mitochondrial adaptation and metabolic resilience: a scientific statement from the American Heart Association. Circulation. 148(22), 1827\u20131845 (2023). https:\/\/doi.org\/10.1161\/CIR.0000000000001185","journal-title":"Circulation"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04784-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04784-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04784-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:46:09Z","timestamp":1789537569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04784-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4784"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04784-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"31 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"299"}}